Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 12;117(1):50.
doi: 10.1007/s00395-022-00958-z.

Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine

Affiliations

Chronic high-rate pacing induces heart failure with preserved ejection fraction-like phenotype in Ossabaw swine

Johnathan D Tune et al. Basic Res Cardiol. .

Abstract

The lack of pre-clinical large animal models of heart failure with preserved ejection fraction (HFpEF) remains a growing, yet unmet obstacle to improving understanding of this complex condition. We examined whether chronic cardiometabolic stress in Ossabaw swine, which possess a genetic propensity for obesity and cardiovascular complications, produces an HFpEF-like phenotype. Swine were fed standard chow (lean; n = 13) or an excess calorie, high-fat, high-fructose diet (obese; n = 16) for ~ 18 weeks with lean (n = 5) and obese (n = 8) swine subjected to right ventricular pacing (180 beats/min for ~ 4 weeks) to induce heart failure (HF). Baseline blood pressure, heart rate, LV end-diastolic volume, and ejection fraction were similar between groups. High-rate pacing increased LV end-diastolic pressure from ~ 11 ± 1 mmHg in lean and obese swine to ~ 26 ± 2 mmHg in lean HF and obese HF swine. Regression analyses revealed an upward shift in LV diastolic pressure vs. diastolic volume in paced swine that was associated with an ~ twofold increase in myocardial fibrosis and an ~ 50% reduction in myocardial capillary density. Hemodynamic responses to graded hemorrhage revealed an ~ 40% decrease in the chronotropic response to reductions in blood pressure in lean HF and obese HF swine without appreciable changes in myocardial oxygen delivery or transmural perfusion. These findings support that high-rate ventricular pacing of lean and obese Ossabaw swine initiates underlying cardiac remodeling accompanied by elevated LV filling pressures with normal ejection fraction. This distinct pre-clinical tool provides a unique platform for further mechanistic and therapeutic studies of this highly complex syndrome.

Keywords: Cardiac function; Coronary blood flow; Hemorrhage; Obesity.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they have no conflict of interest.

Figures

Fig 1.
Fig 1.
Representative images of transverse sections of hearts and baseline pressure-volume relationships from Lean Control and Chronic Paced swine (a). Individual and average data of LV end diastolic volume (b), stroke volume (c), ejection fraction (d), and LV end diastolic pressure (e) from Lean (n = 8), Lean HF (n = 5), Obese (n = 8), and Obese HF (n = 8). Yellow scale bar = 1 cm. P value provided for overall group comparison between control vs. paced swine. *P < 0.05 versus Lean, †P < 0.05 versus Obese.
Fig 2.
Fig 2.
Representative images (a) of cardiac interstitial fibrosis (picrosirius red) and immunofluorescent staining (wheat-germ agglutinin) of myocardium from lean (n = 5–8), lean HF (n = 5) obese (n = 5), and obese HF (n = 5). Staining for cross-sectional area (red), isolectin staining for capillaries (green), and DAPI nuclear stain (blue); scale bar = 20 μm. Individual and average data of interstitial fibrosis (b), myocardial capillary density (c), and myocyte cross-sectional area (d). P value provided for overall group comparison between control vs. paced swine. *P < 0.05 versus Lean, †P < 0.05 versus Obese.
Fig 3.
Fig 3.
Representative traces of LV pressure over time in Lean vs. Lean HF (a) and Obese and Obese HF (b) swine. LV pressure at the beginning (B) and end (E) of diastole in Lean (n = 8) vs. Lean HF (n = 5) (c) and in Obese (n = 8) vs. Obese HF (n = 8) (d). Relationship between LV pressure and LV volume at the beginning and end of the diastolic filling period (e) and LV stroke volume and LV end diastolic volume (f). Regression fits are represented by: Lean = solid turquoise line; Lean HF = solid navy line; Obese = dashed turquoise line; Obese HF = dashed navy line. Shared fits between groups are denoted by side by side regression lines. *P < 0.05 versus Lean, †P < 0.05 versus Obese.
Fig 4.
Fig 4.
Average hemodynamic and metabolic data at rest and in response to acute hemorrhage in Lean (n = 6), Lean HF (n = 4), and Obese HF (n = 5) swine. Effect of reductions in blood pressure on heart rate (a), cardiac index (b), LV end diastolic pressure (c), Pressure Work Index (d), and MVO2 (e). Assessment of cardiac efficiency in the relationship between Pressure Work Index and MVO2 (f). Regression fits are represented by: Lean = solid turquoise line; Lean HF = solid navy line; Obese = dashed turquoise line; Obese HF = dashed navy line. Shared fits between groups are denoted by side by side regression lines.
Fig 5.
Fig 5.
Relationship between LV end diastolic pressure and end diastolic volume at rest and in response to hemorrhage in Lean (n = 6), Lean HF (n = 4), Obese HF (n = 5) swine. Regression fits are represented by: Lean = solid turquoise line; Lean HF = solid navy line; Obese = dashed turquoise line; Obese HF = dashed navy line. Shared fits between groups are denoted by side by side regression lines.
Fig 6.
Fig 6.
Effect of reductions in blood pressure on myocardial oxygen delivery (a), coronary venous PO2 (b), and myocardial lactate uptake (c) in Lean (n = 6), Lean HF (n = 4), and Obese HF (n = 5) swine. Relationship between myocardial oxygen delivery (d), coronary venous PO2 (e), and myocardial lactate uptake (f) vs. MVO2 in Lean (n = 6), Lean HF (n = 4), and Obese HF (n = 5) swine. Regression fits are represented by: Lean = solid turquoise line; Lean HF = solid navy line; Obese = dashed turquoise line; Obese HF = dashed navy line. Shared fits between groups are denoted by side by side regression lines.
Fig 7.
Fig 7.
Effect of reductions in blood pressure on Endocardial to Epicardial flow ratio (Endo:Epi) in the left anterior descending coronary artery (LAD) LV perfusion territory (a), in the left circumflex coronary artery LV perfusion territory (b), and in the RV free wall (c) in Lean (n = 6), Lean HF (n = 4), and Obese HF (n = 5) swine. Regression fits are represented by: Lean = solid turquoise line; Lean HF = solid navy line; Obese = dashed turquoise line; Obese HF = dashed navy line. Shared fits between groups are denoted by side by side regression lines.

References

    1. Altara R, Giordano M, Norden ES, Cataliotti A, Kurdi M, Bajestani SN, Booz GW (2017) Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Front Endocrinol (Lausanne) 8:160 doi:10.3389/fendo.2017.00160 - DOI - PMC - PubMed
    1. Baker HE, Kiel AM, Luebbe ST, Simon BR, Earl CC, Regmi A, Roell WC, Mather KJ, Tune JD, Goodwill AG (2019) Inhibition of sodium-glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization. Basic Res Cardiol 114:25 doi:10.1007/s00395-019-0733-2 - DOI - PMC - PubMed
    1. Barandiaran Aizpurua A, Schroen B, van Bilsen M, van Empel V (2018) Targeted HFpEF therapy based on matchmaking of human and animal models. Am J Physiol Heart Circ Physiol 315:H1670–H1683 doi:10.1152/ajpheart.00024.2018 - DOI - PubMed
    1. Bender SB, DeMarco VG, Padilla J, Jenkins NT, Habibi J, Garro M, Pulakat L, Aroor AR, Jaffe IZ, Sowers JR (2015) Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension 65:1082–1088 doi:10.1161/HYPERTENSIONAHA.114.04912 - DOI - PMC - PubMed
    1. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH (2009) Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234:683–692 doi:10.3181/0812-RM-350 - DOI - PMC - PubMed

Publication types